ARTICLE
1. Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic headand neck cancers: A retrospective analysis.Dr Ranga Rao Rangaraju, Sharma JB, Dewan AK, Anand AK, ShehRawat, Jena A, Chaturvedi AK.Indian Journal of Cancer. Jan-Mar 2012; 49(1):1-5.
2.  Adjuvant therapy of early ovarian cancer. Dr Ranga Rao Rangaraju; Venniyoor AJ; Singh HP. Ind J of Med Paed Oncol.2004; Apr; 25(1): 18-20.
3. Weekly chemotherapy in head and neck malignancies. Dr Ranga Rao Rangaraju ASIA Pacific Cancer Conference. Chennai, 1999. [Abstract]
4. Targeted therapies for non small cell lung cancer. Lung Cancer.Dr Ranga Rao Rangaraju. 2012; 49 (1):1-5.
5. Prognostic factors in ALL. Dr Ranga Rao Rangaraju Proceedings of ISMPO. 2004.
PRESENTATION
Poster Presentation: A case of CaBuccal Mucosa, Recurrent SCC on Erbitux + chemotherapy till progression, head & neck cancer Case Study Poster. Dr Ranga Rao Rangaraju Merck Serono Oncology Summit. Hong Kong, 2012.
6. Dr Ranga Rao Rangaraju, Sarkar U.Medicine Update. 2009; Volume 19 Part II; 955-966.
7. Oncological emergencies. Dr Ranga Rao Rangaraju, Venniyoor AJ. Armed Forces Medical Manual. 2003.
PRESENTATION
Poster Presentation: Weekly chemotherapy in head and neck malignancies. Dr Ranga Rao Rangaraju Asia Pacific Cancer Conference. Chennai, 1999.
8. Unusual responses of refractory solid tumours to thalidomide.Dr Ranga Rao Rangaraju, Konnpal Anil, Ajit Venniyoor, Harinder Singh, Subhash Ranjan and B Kapur. Asia Pacific Journal of Clinical Oncology.2008; Vol 4; issue 2: 113-117
9. Comprehensive cancer care. Dr Ranga Rao Rangaraju Oncology Update, CME Book. 2003; 70-75.
PRESENTATION
An experience with patients of chronic myeloid leukaemia in a service hospital. Dr Ranga Rao Rangaraju, Sarma YS, Laktakia R. APICON. Chennai, 1995.
10. Migration of entire peripherally-inserted central catheter to pulmonary arteries: an unusual complication. Pandey BS, Rustogi P, Anil K, Khatri S, Dr Ranga Rao Rangaraju IJMPO. 2007; 28(1): 33-36.
11. Hodgkin’s disease. Dr Ranga Rao Rangaraju Medicine Update, CME Book. Nov 2002.
PRESENTATION
Dr Ranga Rao Rangaraju has read and presented research papers and delivered lectures at over 110 conferences, professional meets and CMEs at various hospitals, institutes and events across the country and abroad. He has also made presentations for the lay public at community forums, schools, etc.
12. Paraneoplastic hypercalcaemia in association with metabolic complications, in advanced carcinoma of oral cavity. Pande BS, Anil K, Khatri S, Dr Ranga Rao Rangaraju IJMPO; 2007; 28(2): 44-46.
13. Chemo radiotherapy in head and neck cancers. Dr Ranga Rao Rangaraju Oncology Update Proceedings. Nov 2000. AH RR New Delhi.
14. Paraneoplastic Hypercalcaemia in Advanced Carcinoma of Oral Cavity.
15. Paraneoplastic hypercalcaemia in association with metabolic complications, in advanced carcinoma of oral cavity. Pande BS, Anil K, Khatri S, Dr Ranga Rao Rangaraju IJMPO; 2007; 28(2): 44-46.
16. Improved outcome with multimodal management of advanced esthesioneuroblastoma. Dr Ranga Rao Rangaraju, Sarma YS, Mukherjee S, Mukhopadhyay SM. MJAFI.1998; 54,79-81.
17. Adjuvant Therapy of Early Ovarian Cancer.
18. X Ray Diagnosis: Hypertrophic Osteoarthropathy. Dr Ranga Rao Rangaraju, Kalra S. J Applied Medicine(accepted).
19. Bone marrow and peripheral blood stem cell transplantation in the treatment of malignancies. Dr Ranga Rao Rangaraju Proceedings of CME of AFMRC. Feb 1998.
20. Medical Management of Malignancies.
21. Survival benefit and efficacy of gefitinib in recurrent/metastatic head and neck cancers. Dr Ranga Rao Rangaraju, Anil K, Bansal RL, Dhiman A, Khatri S, Rawat S, Dewan K A.IJMPO. 2007.
22.  Impact of prophylactic use of colony stimulating factors on the pattern of neutropenia and infections in moderately intensive chemotherapy. Dr Ranga Rao Rangaraju, Sarma YS, Malik R. MJAFI. 1997; 53, 183-188.
23. Phase II Trial of Neoadjuvant Chemotherapy in Cervical Cancer in Indian Women.
24. Multiple myeloma presenting with hepatic involvement: A rare presentation. Dhiman A, Bansal RL, Sekhon JS, Dr Ranga Rao Rangaraju, Sekhon A, Neeraj. IJMPO. 2007.
25.  Use of long term venous access with Hickmann catheter in patients of acute leukaemia. Kumar R, Kumar Harsh, Dr Ranga Rao Rangaraju MJAFI. 1995; 51,231-236.
26. Medical Management of Malignancies.
27. Colony stimulating factors: current recommendations. Dr Ranga Rao Rangaraju,Venniyoor Ajit Kumar Rajat.Postgraduate Medicine. 2007; pp. 124-136.
28. Tumour associated blood eosinophilia [correspondence]. Kumar H, Sivadas P, Dr Ranga Rao Rangaraju MJAFI.1995 Jan; 51(1): 75-6.
29. Paediatric Acute Myeloblastic Leukemia: Experience with an Intensive Chemotherapy Protocol- A Pilot Study.
30. Treatment of lung cancer in elderly. Parikh P, Dr Ranga Rao Rangaraju Lung Cancer. 2006; Vol 1, 203-211.
31. Haemopoietic growth factors in malignancies. Dr Ranga Rao Rangaraju JAPI. Nov 1995.
32. X Ray Diagnosis: Hypertrophic Osteoarthropathy. Dr Ranga Rao Rangaraju, Kalra S. J Applied Medicine(accepted).
33. Paediatric acute myeloblasticleukemia: experience with an intensive chemotherapy protocol – a pilot study. H P Singh, Dr Ranga Rao Rangaraju, Nair Velu, Venniyoor AJ. Ind J of ISMPO. 2005; 26No.3, 10-14.
34. Integrated approach to the management of patients with advanced germ cell tumors of the testis. R Ravi, R Ranga Rao, V Shanta. JSO. ISSN: 0022-4790, 1994; 55 (1): 47.
35. Pachydermoperiostosis (a report of four cases). Dr Ranga Rao Rangaraju, Tutakne AK, Dham SK, Ahuja IM. MJAFI. 1986; 42. 4,314-8.
36. Targeted therapy in haematological malignancies. Dr Ranga Rao Rangaraju. (Proceedings of APICON 2004).Medicine Update. 2004; Vol 14, 343-353.
37. Block: ECG Diagnosis. Dr Ranga Rao Rangaraju, Kalra SP. Bilevel AV. J App Med. Nov 1989.
38. Triplet combination of gemcitabine, oxaliplatin and continuous infusion 5 FU (FOG) in the treatment of locally advanced or metastatic carcinoma of gall bladder. Venniyoor AJ, Singh HP, Dr Ranga Rao Rangaraju ESMO. 2006. [Abstract]
39. Haemopoietic growth factors in malignancies. Kumar R, Dr Ranga Rao Rangaraju JAPI. Nov 1995.
40. Introduction to interferons. Dr Ranga Rao RangarajuJAPI (suppl). Nov 1995.
Curable cancers. Dr Ranga Rao Rangaraju Proceedings of National Medicine Update. AFMC. 1995.
41.  Moderate doses of alpha interferon 2b therapy with concurrent hydroxyurea in patients of CML benefits early, late chronic phase and accelerated phase. 5-year follow up. Dr Ranga Rao Rangaraju, Sarma YS, Lakhtakia R, Nandi S. Blood. Dec 2000. [Abstract]
42. Immunophenotyping of acute leukaemia. Critical analysis of 35 patients. Kumar H, Kumar R, Sivadas P, Panayach JS, Dr Ranga Rao Rangaraju, Bhardwaj. MJAFI. 1995; 51(3): 165-9.
43. X Ray Diagnosis: Hypertrophic Osteoarthropathy. Dr Ranga Rao Rangaraju, Kalra S. J Applied Medicine(accepted).

Abstracts

    • Venniyoor AJ, Singh HP, Dr Ranga Rao Rangaraju Triplet combination of gemcitabine, oxaliplatin and continuous infusion 5 FU (FOG) in the treatment of locally advanced or metastatic carcinoma of gall bladder. ESMO 2006.
    • Dr Ranga Rao Rangaraju, Sarma YS, Lakhtakia R, Nandi S. Moderate doses of alpha interferon 2 b therapy with concurrent hydroxyurea in patients of CML benefits early, late chronic phase and accelerated phase. 5 year follow up. Blood. Dec 2000.
    • Dr Ranga Rao Rangaraju Weekly Chemotherapy in Head and neck malignancies. ASIA Pacific Cancer Conference, Chennai, 1999.
  • Kumar H; Sivadas P; Dr Ranga Rao Rangaraju; Bhardwaj JR; Harsh Kumar; R Rangarao, Tumour associated blood eosinophilia [correspondence]. MJAFI, 1995 Jan 51 (1): 75-76

Posters

    • Dr Ranga Rao Rangaraju, A Case of Ca Buccal Mucosa, Recurrent SCC on Erbitux + Chemotherapy till Progression, Head & Neck Cancer Case Study Poster, Merck Serono Oncology Summit, Hong Kong (2012).
    • Dr Ranga Rao Rangaraju Weekly Chemotherapy in Head and neck malignancies. ASIA Pacific Cancer Conference, Chennai, 1999.
    • Dr Ranga Rao Rangaraju, Sarma YS, Laktakia R. An Experience with patients 
of Chronic Myeloid Leukaemia in a service hospital. APICON, 
Madras, 1995.
  • Dr Ranga Rao Rangaraju, Shanta S, Impact of Chemotherapy on Stage I Non 
Seminomatous Germ Cell Tumours. UICC, New Delhi, 1994.

Papers Read/Lectures delivered:

  • More than 100 papers read in local, regional, National and international level conferences.
  • Over 150 lectures delivered for doctors, medical students, nurses and para medical staff in various hospital, institutions, medical colleges in India and abroad.

Community/ Social Forums: Presentations

  • More than 150 public lectures delivered in various places in the country, and abroad.